Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal
Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal
复制标题
DOI：
10.1111/add.13517
复制
发表时间：
2016-12-01
期刊：
影响因子：
6
通讯作者：
Degenhardt, Louisa
中科院分区：
文献类型：
--
作者：
Nielsen, Suzanne;Menon, Nadia;Degenhardt, Louisa
目的鉴于通过社区药房扩大纳洛酮供应的潜力，本研究的目的是评估澳大利亚药剂师的：（1）对预防用药过量的支持水平，（2）纳洛酮供应的障碍和促进因素以及（3）有关纳洛酮管理的知识。设计来自社区药房的全国代表性样本的在线调查。设置澳大利亚，2015年9月至11月。参与者总计1317 名社区药剂师受邀参与，收到 595 份回复（45.1%）。测量我们评估了对减少伤害的态度、对预防过量用药的支持、对纳洛酮的态度和知识。我们测试了减少伤害的态度与纳洛酮供应不同方面之间的关联。结果药剂师愿意接受有关纳洛酮的培训（n = 479，80.5％）并提供纳洛酮处方（n = 537，90.3％）。较少（n=234，40.8%）愿意提供非处方纳洛酮。对减少伤害的积极态度与更愿意通过处方[比值比 (OR)=1.15，95% 置信区间 (CI)=1.11-1.19] 和非处方纳洛酮 (OR=1.13，95% CI=1.09-1.17) 提供纳洛酮相关。很少有药剂师相信他们可以识别合适的患者（n = 203，34.1％）并对他们进行药物过量和纳洛酮使用方面的教育（n = 190，31.9％）。纳洛酮知识的平均得分为 1.8（满分 5 分）（标准差 1.7）。超过一半的样本认为缺乏时间、培训、知识和报销是提供纳洛酮的潜在障碍。结论澳大利亚的社区药剂师似乎愿意提供纳洛酮。关于纳洛酮药理学和给药的知识水平较低，凸显了对药剂师进行药物过量预防培训的重要性。
AimGiven the potential to expand naloxone supply through community pharmacy, the aim of this study was to estimate Australian pharmacists': (1) level of support for overdose prevention, (2) barriers and facilitators for naloxone supply and (3) knowledge about naloxone administration.DesignOnline survey from nationally representative sample of community pharmacies.SettingAustralia, September-November 2015.ParticipantsA total of 1317 community pharmacists were invited to participate with 595 responses (45.1%).MeasurementsWe assessed attitudes towards harm reduction, support for overdose prevention, attitudes and knowledge about naloxone. We tested the association between attitudes towards harm reduction and different aspects of naloxone supply.FindingsPharmacists were willing to receive training about naloxone (n=479, 80.5%) and provide naloxone with a prescription (n=537, 90.3%). Fewer (n=234, 40.8%) were willing to supply naloxone over-the-counter. Positive attitudes towards harm reduction were associated with greater willingness to supply naloxone with a prescription [odds ratio (OR)=1.15, 95% confidence interval (CI)=1.11-1.19] and over-the-counter (OR=1.13, 95% CI=1.09-1.17). Few pharmacists were confident they could identify appropriate patients (n=203, 34.1%) and educate them on overdose and naloxone use (n=190, 31.9%). Mean naloxone knowledge scores were 1.8 (standard deviation 1.7) out of 5. More than half the sample identified lack of time, training, knowledge and reimbursement as potential barriers for naloxone provision.ConclusionCommunity pharmacists in Australia appear to be willing to supply naloxone. Low levels of knowledge about naloxone pharmacology and administration highlight the importance of training pharmacists about overdose prevention.